KSA
CVS icon

Ken Stern & Associates’s CVS Health CVS Stock Holding History

Ken Stern & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$305K Buy
3,870
+550
+17% +$39.3K 0.13% 101
2018
Q2 		$214K Sell
3,320
-519
-14% -$34.2K 0.1% 122
2018
Q1 		$239K Buy
3,839
+1,070
+39% +$76.8K 0.11% 111
2017
Q4 		$201K Sell
2,769
-1,131
-29% -$82.2K 0.09% 115
2017
Q3 		$320K Sell
3,900
-69
-2% -$5.46K 0.14% 80
2017
Q2 		$320K Hold
3,969
– – 0.15% 79
2017
Q1 		$327K Buy
3,969
+896
+29% +$71.5K 0.15% 79
2016
Q4 		$242K Sell
3,073
-983
-24% -$79.5K 0.13% 97
2016
Q3 		$361K Hold
4,056
– – 0.25% 57
2016
Q2 		$388K Buy
4,056
+82
+2% +$8.17K 0.3% 52
2016
Q1 		$412K Buy
3,974
+617
+18% +$60K 0.29% 47
2015
Q4 		$328K Buy
+3,357
New +$329K 0.22% 64
2015
Q1 		– Sell
-21,724
Closed -$2.09M – 77
2014
Q4 		$2.09M Buy
+21,724
New +$1.91M 1.63% 18

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ken Stern & Associates's CVS Position: Q3 2018 in Review

Ken Stern & Associates increased its CVS Health (CVS) stake by 17% in Q3 2018, buying an estimated $39.3K and bringing the position to 3,870 shares worth $305K. The position accounts for 0.13% of the portfolio, ranked #101.

Ken Stern & Associates first reported a position in CVS in Q4 2014 and has held it in 13 quarters since. The position peaked at $2.09M in Q4 2014. 1,599 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

  • Ken Stern & Associates held 3,870 shares of CVS Health worth $305K as of Q3 2018.
  • Ken Stern & Associates bought 550 CVS Health shares in Q3 2018, an estimated $39.3K.
  • CVS Health made up 0.13% of Ken Stern & Associates's portfolio in Q3 2018, its #101 holding.
  • Ken Stern & Associates first reported a position in CVS Health in Q4 2014 and has held it in 13 quarters since.
  • Ken Stern & Associates's CVS Health position peaked at $2.09M in Q4 2014.
  • 1,599 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.